CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Open-market sale Director sold 100,000 shares at $19.02 ($1,902,090)
- 4 Open-market sale General Counsel sold 27,229 shares at $17.92 ($488,058)
- 4 Open-market sale Director sold 33,799 shares at $18.45 ($623,534)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market sale Director sold 13,174 shares at $18.00 ($237,139)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 9,541 shares at $18.67 ($178,107)
- 4 Open-market sale General Counsel sold 27,230 shares at $18.69 ($508,839)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 12,805 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Shares withheld for taxes President and CEO gave up 14,757 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 9,542 shares at an average $20.06 ($191,392)
Page 28 of 77 · 1,527 filings